Ribavirin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00811 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 73 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | chronic hepatitis B virus infection | KG + DL |
| 2 | idiopathic copper-associated cirrhosis | KG + DL |
| 3 | hepatopulmonary syndrome | KG + DL |
| 4 | hepatoportal sclerosis | KG + DL |
| 5 | primitive portal vein thrombosis | KG + DL |
| 6 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 7 | hepatic porphyria | KG + DL |
| 8 | IgG4-related pachymeningitis | KG + DL |
| 9 | eosinophilic angiocentric fibrosis | KG + DL |
| 10 | IgG4-related aortitis | KG + DL |
| 11 | IgG4-related mediastinitis | KG + DL |
| 12 | IgG4-related mesenteritis | KG + DL |
| 13 | hepatitis B virus infection | KG + DL |
| 14 | IgG4-related retroperitoneal fibrosis | KG + DL |
| 15 | IgG4-related hepatopathy | KG + DL |
| 16 | urinary tract infection (disease) | KG + DL |
| 17 | gonococcal urethritis | KG + DL |
| 18 | Ureaplasma urethritis | KG + DL |
| 19 | xanthogranulomatous pyelonephritis | KG + DL |
| 20 | hepatitis D virus infection | KG + DL |
| 21 | uterine inflammatory disease | KG + DL |
| 22 | disorder of tyrosine metabolism | KG + DL |
| 23 | pyelonephritis | KG + DL |
| 24 | disorder of phenylalanine metabolism | KG + DL |
| 25 | teratogenic Pierre Robin syndrome | KG + DL |
| 26 | tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | KG + DL |
| 27 | biotin metabolic disease | KG + DL |
| 28 | idiopathic eosinophilic myositis | KG + DL |
| 29 | inflammatory myopathy with abundant macrophages | KG + DL |
| 30 | vitamin deficiency disorder | KG + DL |
| 31 | type I complement component 8 deficiency | KG + DL |
| 32 | HIV infectious disease | KG + DL |
| 33 | iron deficiency anemia | KG + DL |
| 34 | hepatitis, viral, animal | KG + DL |
| 35 | immune-mediated necrotizing myopathy | KG + DL |
| 36 | hepatitis E virus infection | KG + DL |
| 37 | hepatitis A virus infection | KG + DL |
| 38 | antisynthetase syndrome | KG + DL |
| 39 | Omsk hemorrhagic fever | KG + DL |
| 40 | Kyasanur forest disease | KG + DL |
| 41 | common wart | KG + DL |
| 42 | focal myositis | KG + DL |
| 43 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 44 | simian immunodeficiency virus infection | KG + DL |
| 45 | feline acquired immunodeficiency syndrome | KG + DL |
| 46 | hereditary hemochromatosis | KG + DL |
| 47 | proteinuria | KG + DL |
| 48 | hyperphenylalaninemia due to tetrahydrobiopterin deficiency | KG + DL |
| 49 | hemosiderosis | KG + DL |
| 50 | Heiner syndrome | KG + DL |
(Showing top 50 of 73 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.